Faculty profile

Fred Saad

Back to faculty

ProfessorDépartement de chirurgieUniversité de Montréal

Fred Saad

Professor

Département de chirurgie

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
158 publications in the last five years, latest in 2026.
Senior (last) author on 21 recent papers, a sign of leading a research group.
Supervisor on 1 trainee award (1 CIHR), most recently in 2025.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

158

Publications

1,324

Citations

121

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer
European Urology Open Science · 2026 · senior author
Use of concomitant G-CSF in maintaining efficacious dose and safe delivery of docetaxel in combination with darolutamide in ARASENS: A phase III study
European Journal of Cancer · 2026
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.
European urology oncology · 2026

All 158 publications

Latest funding

The IGF-1/mTORC1 axis in prostate cancer : early-life and post-diagnosis nutrition and physical activity-based interventions
CIHR · 2025 · Supervisor
$140,000
Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies
CIHR · 2025 · Co-investigator
The impact of 1-year of adjuvant androgen deprivation following radical prostatectomy on prostate cancer recurrence: An internal pilot randomized trial
CIHR · 2021 · Co-investigator
$100,000

All 6 grants and awards

From the 150 most recent of 158 publications.

Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer

Stacey A. Kenfield, Nicolas H. Hart, Kerry S. Courneya, Rosemary Greenwood, June M. Chan, Jennette D. Sison, Li Zhang, Sarah Maria Rudman, Leah Ung, Moritz Schumann, Erin Lynn Van Blarigan, Sam McKeown, Charles J. Ryan, James W.F. Catto, Daniel Abido Galvao, Robert Usher Newton, Fred Saad, Robert Usher Newton, Fred Saad, Arash Asher, Freerk Theeagnus Baumann, Wilhelm Bloch, Hans Bussmann, James W.F. Catto, June M. Chan, Jeff Coombes, Kerry S. Courneya, Stephen P. Finn, Daniel Abido Galvao, Rosemary Greenwood, et al. (53 authors)

European Urology Open Science20265 citationsSenior authorOpen Access

DOI: 10.1016/j.euros.2025.12.001 PMID: 41561488

Use of concomitant G-CSF in maintaining efficacious dose and safe delivery of docetaxel in combination with darolutamide in ARASENS: A phase III study

Ong M, Suzuki H, Smith M, Tombal B, Hussain M, Saad F, Fizazi K, Verholen F, Pham H, Srinivasan S

European Journal of Cancer20262 citationsOpen Access

DOI: 10.1016/j.ejca.2026.116264

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Armstrong AJ, Saad F, Oya M, Vianna K, Özgüroğlu M, Gedye C, Buchschacher GL, Lee JY, Emmenegger U, Navrátil J, Virizuela JA, Salazar A, Maillet D, Uemura H, Hosius C, McGuinness D, Degboe A, Clarke N

European urology oncology20261 citationsOpen Access

DOI: 10.1016/j.euo.2025.09.010 PMID: 41253648

Genetic testing practices among specialist physicians who treat prostate cancer: Updated survey of Canadian practitioners

Yip SM, Niazi T, Hamilton RJ, Kolinsky MP, Gotto GT, Hotte SJ, Ong M, Rendon RA, Ferrario C, Saad F

Journal of the Canadian Urological Association2026Open Access

DOI: 10.5489/cuaj.9466

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

Moussa H, Tourigny R, Robitaille K, Bussières V, Fadel J, Ben Souilah F, Diabaté L, Hovington H, Bettan L, Lacombe L, Dujardin T, Lodde M, Toren P, Aprikian A, Saad F, Carmel M, Jeldres C, Lamarche B, Bergeron A, Fradet Y, Fradet V, Network BIOCaPPE

BMJ open2026Open Access

DOI: 10.1136/bmjopen-2025-111118 PMID: 42209010

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir

Ong M, Morash C, Hamilton RJ, Gotto GT, Rendon RA, Malone S, Antebi E, Kolinsky MP, Hotte SJ, N. K

Future Oncology2026Open Access

DOI: 10.1080/14796694.2026.2665814

Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Gambaro K, Rachedi K, Basik M, Batist G, Saad F, Hassan S, Mes-Masson AM, Boudreau D, Vincent F, St-Hilaire E, Mackay H, Abdelsalam M, Yip SM, Hanel R, Shokar S, Senhaji Mouhri Z, Badin M, Klein-Panneton K, Awan AA, Marques M

Advances in therapy2026

DOI: 10.1007/s12325-026-03545-z PMID: 41806276

Luteinizing hormone-releasing hormone in prostate cancer treatment: from hypothalamic discovery to clinical translation.

Benisti S, Saad F, Delouya G, Taussky D

JNCI cancer spectrum2026

DOI: 10.1093/jncics/pkag075 PMID: 42439540

Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.

George DJ, Fizazi K, Morgans AK, McManus HD, Yip YY, Srinivasan S, Duflot M, Upton A, Saad F

European journal of cancer (Oxford, England : 1990)2026Senior author

DOI: 10.1016/j.ejca.2026.116982 PMID: 42617299

Age-related Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of the Phase 3 ARASENS Trial.

Carles J, Tombal B, Hussain M, Saad F, Fizazi K, Montesa Pino Á, Méndez-Vidal MJ, Rodriguez-Vida A, Castellano D, Borrega P, Adorjan P, Moretones C, Dissanayake M, Smith MR

European urology oncology2026

DOI: 10.1016/j.euo.2025.10.001 PMID: 41193271

The IGF-1/mTORC1 axis in prostate cancer : early-life and post-diagnosis nutrition and physical activity-based interventions

SupervisorCIHR2025Canada Postdoctoral Research Award (CPRA) program

Principal investigators: Teixeira Nascimento, Vitor

Keywords: Androgen Receptor Pathway Inhibitor; Developmental Origins Of Health And Disease; Glucose; Glutamine; Igf-1; Leucine; Mtorc1; Nutrition; Physical Activity; Prostate Cancer

$140,000

Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies

Co-investigatorCIHR2025Team Grant: Bringing Biology to Cancer Prevention - General Pool

Principal investigators: Fradet, Vincent; Isabel, Sandra; Labbé, David

Keywords: Avatar Mouse Models; Biomarkers; Genetically Engineered Mouse Models Of Prostate Cancer; Gut Microbiota; Lifestyle Habits; Metagenomics; Observational Study; Prebiotics; Probiotics; Prostate Cancer Risk

The impact of 1-year of adjuvant androgen deprivation following radical prostatectomy on prostate cancer recurrence: An internal pilot randomized trial

Co-investigatorCIHR2021Project Grant - Priority Announcement: Patient-Oriented Research

Principal investigators: Breau, Rodney H; Fergusson, Dean A; Lavallée, Luke T

Keywords: Adjuvant; Androgen Deprivation; High Risk; Prevention Of Recurrence; Prostate Cancer; Radical Prostatectomy; Urology

$100,000

Towards optimization of anti-hormonal therapy in advanced prostate cancer

Co-investigatorCIHR2019Project Grant

Principal investigators: Guillemette, Chantal; Levesque, Eric

Keywords: Anti-Androgens; Drug Metabolism; Metabolomics; Pharmacogenomics; Predictive Markers; Prostate Cancer; Steroids

$765,000

Diagnosis of Aggressive Prostate Cancer Using Key Features of Raman Spectroscopy

Co-investigatorCIHR2019Project Grant

Principal investigators: Trudel, Dominique; Leblond, Frederic

Keywords: Coherent Antistokes Raman Spectroscopy; Diagnosis; Imaging Mass Spectrometry; Intraductal Carcinoma Of The Prostate; Machine-Learning; Prostate Cancer; Raman Spectroscopy

$765,000

Clinical evaluation of surface-plasmon resonance and nanoparticle-based fluorescent detection of serum biomarkers

Co-investigatorCIHR2012Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Pelletier, Joelle N; Masson, Jean-Francois

Keywords: Cancer Biomarker; Cancer Treatment; Fluorescence; Nanoparticle; Pharmacokinetics; Portable Device; Surface Plasmon Resonance; Ultra-Low Fouling Surfaces

$328,059

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Fred Saad

Research

Latest papers

Latest funding

Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer

Use of concomitant G-CSF in maintaining efficacious dose and safe delivery of docetaxel in combination with darolutamide in ARASENS: A phase III study

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Genetic testing practices among specialist physicians who treat prostate cancer: Updated survey of Canadian practitioners

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir

Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Luteinizing hormone-releasing hormone in prostate cancer treatment: from hypothalamic discovery to clinical translation.

Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.

Age-related Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of the Phase 3 ARASENS Trial.

The IGF-1/mTORC1 axis in prostate cancer : early-life and post-diagnosis nutrition and physical activity-based interventions

Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies

The impact of 1-year of adjuvant androgen deprivation following radical prostatectomy on prostate cancer recurrence: An internal pilot randomized trial

Towards optimization of anti-hormonal therapy in advanced prostate cancer

Diagnosis of Aggressive Prostate Cancer Using Key Features of Raman Spectroscopy

Clinical evaluation of surface-plasmon resonance and nanoparticle-based fluorescent detection of serum biomarkers

Frequent collaborators

Kim Chi

Bobby Shayegan

Ricardo Rendon

Scott Morgan

Alan So

Martin Gleave

Michael Ong

Armen Aprikian

Sebastien Hotte

Neil Fleshner

Eric Vigneault

Srikala Sridhar

Rodney Breau

Dominique Trudel

Simone Chevalier

Antonio Finelli

Luke Lavallée

Guila Delouya

Jonathan Izawa

Andrew Loblaw

Alain Bergeron

Yves Fradet

André-Guy Martin

Louis Lacombe